Diagnostics for monitoring the development of the HIV reservoar
| Reference number | |
| Coordinator | Karolinska Institutet - Karolinska Institutet Inst f biovetenskaper & näringslära |
| Funding from Vinnova | SEK 3 000 000 |
| Project duration | April 2024 - March 2026 |
| Status | Completed |
| Venture | Swelife - Samverkansprojekt för bättre hälsa |
| Call | Swelife - Collaborative projects for better health autumn 2023 |
Important results from the project
The aim of the project has been to develop a diagnostic method, CADseq, to monitor the individual need for antiviral treatment against HIV. Collaboration in the project contributed to the CADseq method being tested in a clinical setting, anchoring in the patient group worked well and contributed to valuable insights into the needs of the group living with HIV.
Expected long term effects
The project has strengthened expertise in research collaboration and innovation-related project, with a strong impact on the patient group. In the longer term, this contributes to: • better adaptation of advanced diagnostics to care and patient needs, • increased quality in HIV care follow-up and communication, • strengthened collaboration between academia, care and civil society in life science. • Strengthened knowledge and commitment within the patient group around the project´s aim and theme
Approach and implementation
The collaboration and division of labor between the project partners worked well, with each partner contributing their unique expertise. KI was responsible for method development, KUL for technical validation, KUS for clinical perspective, while Noaks Ark ensured the patient perspective. The activities within business development and patient engagement were carried out according to plan with good results. The technical verification proved to be more complex than expected.